Feb. 27 court date for Charter test of stem cell program; Foes say enterprise is illegal because it's outside state control
By San Francisco Chronicle,
San Francisco Chronicle
| 12. 07. 2005
Alameda County Superior Court Judge Bonnie Sabraw set a trial for Feb. 27 to decide whether California's Proposition 71 stem cell program violates the state Constitution.
Sabraw presided over a 30-minute hearing in her Hayward courtroom Tuesday to work out a timetable for the next critical phase in litigation brought by plaintiffs who say the voter-approved stem cell enterprise is illegal because it operates outside "the exclusive management and control of the state."
While the court proceeding was under way, stem cell policymakers were in Southern California to lay groundwork for their long-awaited first round of financing. Their goal is to generate up to $50 million, more than enough to cover initial training grants for would-be stem cell scientists at California medical schools and other nonprofit research institutions.
Officials meeting at City of Hope Cancer Research Center outside Los Angeles adopted guidelines governing profit rights and other "intellectual property" rules for researchers receiving Prop. 71 grants. A much more detailed review of final policies is just beginning.
Critics argue that stem cell policy makers are allowing researchers too much control...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...